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Misfolded proteins of the endoplasmic reticulum (ER)
are retrotranslocated into the cytosol, polyubiquiti-
nated, and degraded by the proteasome, a process
called ER-associated protein degradation (ERAD).
Here, we use purified components from Saccharo-
myces cerevisiae to analyze the mechanism of retro-
translocation of luminal substrates (ERAD-L), reca-
pitulating key steps in a basic process in which the
ubiquitin ligase Hrd1p is the only required membrane
protein. We show that Hrd1p interacts with sub-
strate through its membrane-spanning domain and
discriminates misfolded from folded polypeptides.
Both Hrd1p and substrate are polyubiquitinated, re-
sulting in the binding of Cdc48p ATPase complex.
Subsequently, ATP hydrolysis by Cdc48p releases
substrate from Hrd1p. Finally, ubiquitin chains are
trimmed by the deubiquitinating enzyme Otu1p,
which is recruited and activated by the Cdc48p com-
plex. Cdc48p-dependent membrane extraction of
polyubiquitinated proteins can be reproduced with
reconstituted proteoliposomes. Our results suggest
a model for retrotranslocation in which Hrd1p forms
a membrane conduit for misfolded proteins.
INTRODUCTION
Protein homeostasis in the endoplasmic reticulum (ER) is main-
tained by a quality control system. When a protein misfolds, it
is retained in the ER and ultimately retrotranslocated into the
cytosol, polyubiquitinated, and degraded by the proteasome.
This pathway is referred to as ER-associated protein degrada-
tion (ERAD) (for review, see Bagola et al., 2011; Brodsky,
2012). It alleviates cytotoxic stress imposed by protein misfold-
ing and is implicated in numerous diseases (Guerriero and Brod-
sky, 2012). ERAD is found in all eukaryotic cells but is best
understood in Saccharomyces cerevisiae. Here, substrates use
three ERAD pathways (ERAD-L, -M, or -C), depending on
whether the misfolded domain is localized in the ER lumen, in-Cside the ER membrane, or at the cytosolic side of the ER mem-
brane (Carvalho et al., 2006; Huyer et al., 2004; Vashist and
Ng, 2004). The pathways use distinct ubiquitin ligase complexes.
ERAD-L requires a heterotetrameric membrane protein com-
plex, the Hrd1p complex, comprised of the ubiquitin ligase
Hrd1p and three additional membrane proteins (Hrd3p, Usa1p,
and Der1p). ERAD-M also requires Hrd1p but only a subset of
the other components, and ERAD-C uses the ubiquitin ligase
Doa10p. On the cytosolic side of the ERmembrane, all pathways
require an ATPase complex, which includes the ATPase Cdc48p
and the cofactors Ufd1p and Npl4p.
Among the ERAD pathways, ERAD-L is arguably most com-
plex, as polypeptides have to be inserted into and moved across
the ER membrane. ERAD-L begins with the recognition of a mis-
folded protein in the ER lumen, which is best understood for
misfolded glycoproteins (for review, see Xie and Ng, 2010). The
N-linked glycan of these proteins is trimmed to generate a termi-
nal a-1,6-mannose residue, which is recognized by the luminal
protein Yos9p. Yos9p binds to the luminal domain of Hrd3p,
which also binds amisfolded segment around the glycan-attach-
ment site of the substrate. Once a segment of the substrate
emerges on the cytoplasmic side of the ERmembrane, it is poly-
ubiquitinated by the RING finger domain of Hrd1p (Bays et al.,
2001a; Bordallo et al., 1998). The major ubiquitin-conjugating
enzyme participating in this reaction is Ubc7p, which also re-
quires the activator Cue1p (Bays et al., 2001a; Biederer et al.,
1997). The recruitment of the Cdc48p complex to the Hrd1p
complex involves recognition of a polyubiquitin chain by the
cofactor Ufd1p/Npl4p (Meyer et al., 2002). However, it is unclear
whether the recruitment requires the ubiquitin chain to be
attached to the substrate, to Hrd1p, or to an unknown com-
ponent. The binding of Cdc48p to the membrane might be
facilitated by the adaptor protein Ubx2p (Neuber et al., 2005;
Schuberth and Buchberger, 2005). Cdc48p is then thought to
pull on the polyubiquitinated polypeptide substrate to move it
into the cytosol (Bays et al., 2001b; Jarosch et al., 2002; Rabino-
vich et al., 2002; Ye et al., 2001). Recent experiments have also
implicated deubiquitinating enzymes (DUBs) in ERAD (for review,
see Liu and Ye, 2012). Several DUBs associate with Cdc48p or
its mammalian homolog p97, and the overexpression of domi-
nant-negative forms blocks ERAD in mammalian cells. However,
it remains unclear how DUBs participate in ERAD.ell 158, 1375–1388, September 11, 2014 ª2014 Elsevier Inc. 1375
The events of ERAD-L inside the ER membrane are less well
understood. Hrd1p seems to be a central component, as its
overexpression bypasses the need for the other membrane
components, as well as for the luminal protein Yos9p (Carvalho
et al., 2010; Denic et al., 2006; Garza et al., 2009; Plemper
et al., 1999). Under these conditions, glycan trimming is not
required and both glycosylated and nonglycosylated proteins
are degraded. All downstream cytosolic components, including
the Cdc48p complex, are still required. Hrd1p overexpression
makes Hrd1p unstable and slows, but does not abolish, cell
growth. These results suggest that Hrd1p is the only membrane
component required for a basic ERAD-L process. The minimal
components required for retrotranslocation therefore comprise
Hrd1p, Ubc7p, Cue1p, and the Cdc48p complex. Because
Hrd1p is a multispanning membrane protein, it is a good candi-
date to be part of a retrotranslocation channel. In fact, cross-
linking experiments show that a retrotranslocating substrate
interacts with Hrd1p (Carvalho et al., 2010). However, the exact
function of Hrd1p during retrotranslocation remains unclear.
Our knowledge on ERAD-L comes from genetics and bio-
chemical experiments in intact cells. In vitro reconstitution of
ERAD-L using purified components is critical to demonstrate
that all ERAD components have been identified. Even more
importantly, reconstitution experiments are instrumental in ad-
dressing the molecular mechanism of ERAD. Here, we have
recapitulated crucial reactions of a basic ERAD-L process with
purified S. cerevisiae components in both detergent and recon-
stituted proteoliposomes. Our results suggest a mechanistic
model for how misfolded luminal ER proteins associate with
Hrd1p inside the ER membrane and how they are extracted by
Cdc48p on the cytoplasmic side of the membrane.
RESULTS
Direct Interaction of ERAD-L Substrates with Hrd1p
In vivo experiments suggested that Hrd1p is the only membrane
protein required for a basic ERAD-L process (Carvalho et al.,
2010). We therefore tested whether purified Hrd1p directly in-
teracts with purified misfolded proteins. We used a well-charac-
terized ERAD-L substrate, misfolded procarboxypeptidase Y
(CPY*), which differs from the native protein by a single-point
mutation (Finger et al., 1993). His-tagged CPY* was purified in
urea after expression in S. cerevisiae, but it remained soluble
after removal of urea (Figure S1A available online). To facilitate
detection, CPY* was labeled with a fluorescent dye (Figure S1B).
Hrd1p with a C-terminal streptavidin-binding peptide (SBP)
tag (Hrd1p-SBP) was purified from S. cerevisiae in the detergent
decyl maltose neopentyl glycol (DMNG). Although Hrd1p ap-
peared pure by SDS-PAGE (Figure S1C), it was heterogeneous
in size by gel filtration (Figure S1D), consistent with it forming
homo-oligomers in vivo (Carvalho et al., 2010).
For binding experiments, we mixed labeled CPY* with
increasing concentrations of immobilized Hrd1p. Quantification
of the bound and nonbound fractions gave an apparent affinity
of 30 nM (Figures 1A and 1B). Wild-type pro-CPY (CPY) did
not bind to Hrd1p (Figure 1B; see Figures S1A and S1B for puri-
fied and labeled protein, respectively). Even when CPY was
treated like CPY*, i.e., denatured in urea followed by removal1376 Cell 158, 1375–1388, September 11, 2014 ª2014 Elsevier Inc.of urea, only a small fraction was able to bind (Figure 1B). This
suggests that Hrd1p can discriminate misfolded from folded
polypeptides.
Hrd1p also bound other misfolded CPY variants, such as a
C-terminal fragment of CPY* (sCPY*), which is an ERAD-L sub-
strate in vivo (Carvalho et al., 2010). sCPY* was purified as a
mixture of glycosylated and nonglycosylated species (as shown
by treatment with peptide N-glycosidase F; Figure S1A) and
was labeled with a fluorescent dye at a single C-terminal Cys
residue (Figure S1B). sCPY* bound to Hrd1p with significantly
lower affinity than did CPY* (Figures 1C and 1D; 300 nM). Gly-
cosylated and nonglycosylated sCPY* bound equally well to
Hrd1p, consistent with the fact that other ERAD components
are required for their discrimination and with both species be-
ing substrates in Hrd1p-overexpressing cells (Denic et al.,
2006). A fusion of sCPY* with dihydrofolate reductase (DHFR)
bound more tightly than did sCPY*, whereas a fusion with
GFP (sCPY*-GFP) bound more weakly (Figure 1E; purity shown
in Figures S1A and S1B). These differences correlate with the
tendency of these proteins to aggregate; the concentration of
urea required to keep these proteins in solution was lowest
for sCPY*-GFP, intermediate for sCPY*, and highest for
sCPY*-DHFR (data not shown). Purified GFP or DHFR alone,
or bovine serum albumin, did not bind (Figure 1E; data not
shown; purified DHFR and GFP are shown in Figures S1 and
S1B, respectively). Thus, Hrd1p binds selectively to unfolded
polypeptides.
The membrane-embedded domain of Hrd1p is necessary and
sufficient for substrate interaction, as the C-terminal cytoplasmic
domain (Hrd1p-c) did not bind sCPY* (Figure 1F) and a fusion of
the membrane-embedded domain of Hrd1p with GFP (Hrd1p-
TM-GFP) bound substrate with the same affinity as wild-type
Hrd1p (Figure 1F; purity of the proteins shown in Figure S1C).
A folded state of the transmembrane segments (TMs) seems to
be required for substrate interaction, as full-length Hrd1p was
unstable in detergents other than DMNG, and this correlated
with the loss of substrate binding (data not shown).
We used the high-affinity substrate sCPY*-DHFR to test
whether substrate binds equally well to different oligomeric
states of Hrd1p. Labeled sCPY*-DHFR alone behaved in gel
filtration as a homogeneous, low-molecular weight species (Fig-
ure 1G), as the low concentration and the presence of detergent
prevented its aggregation. When labeled sCPY*-DHFR was
mixed with a 100-fold excess of Hrd1p, most substrate mole-
cules migrated at very high molecular weight, where few Hrd1p
molecules were found, and vice versa, the smallest-sized
Hrd1p species did not contain bound substrate. Because
sCPY*-DHFR is much smaller than are the Hrd1p oligomers
(40 kDa versus >250 kDa), the size shift of the substrate in-
dicates that it preferentially binds to high-molecular weight
Hrd1p oligomers.
Substrate Polyubiquitination by Hrd1p
Next, we tested whether Hrd1p polyubiquitinates bound sub-
strate. To this end, we purified the ubiquitin-conjugating enzyme
Ubc7p and its activator Cue1p (Figure S1C). Cue1p is a single-
spanning membrane protein (Biederer et al., 1997), but in our
experiments the full-length protein and a truncated version
CA
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Figure 1. Substrate Interaction with Hrd1p
(A) Fluorescently labeled CPY* (10 nM) was incu-
bated with increasing concentrations of bead-im-
mobilized SBP-tagged Hrd1p (Hrd1p). The bound
and unbound fractions were analyzed by SDS-
PAGE and fluorescence scanning.
(B) Quantification of four different experiments as in
(A). Fitting of the data points gives an apparent
dissociation constant of 30 nM. Also shown are
experiments with wild-type CPY, either purified as
a native protein or after unfolding and refolding, as
done with CPY*.
(C) As in (A) but with sCPY* (100 nM).
(D) Quantification of three different experiments as
in (C). The apparent dissociation constant is
300 nM.
(E) Quantification of binding experiments of wild-
type Hrd1p with fluorescently labeled sCPY*-
DHFR (10 nM), sCPY*-GFP (100 nM), DHFR
(100 nM), or GFP (100 nM).
(F) As in (C), but sCPY* was incubated with wild-
type Hrd1p, a fusion of the TMs of Hrd1p with GFP
(Hrd1p-TM-GFP), the cytoplasmic domain of
Hrd1p (Hrd1p-c), or GFP.
(G) sCPY*-DHFR (200 nM) labeled with DyLight800
was incubated with a mixture of unlabeled Hrd1p
(20 mM) and Hrd1p (200 nM) labeled with Dy-
Light680. The sample was subjected to gel filtration
in a buffer containing 120 mMDMNG, and fractions
were analyzed in two fluorescence channels. A
control was performed with labeled sCPY*-DHFR
alone. The arrows indicate the void volume, and the
retention volume of size standards.
See also Figure S1.containing only the cytosolic domain (Cue1p-c) behaved iden-
tically (data not shown). When Hrd1p was incubated with
fluorescently labeled CPY*, Ubc7p, Cue1p-c, purified Uba1p
(Figure S1C), ubiquitin, and ATP, polyubiquitinated CPY* was
generated (Figure 2A). The reaction rate depended mostly on
the concentrations of Hrd1p and Ubc7p and was complete
within 60 min. No polyubiquitination was observed if ATP,
Uba1p, Ubc7p, or Hrd1p were omitted or if an inactive Hrd1p
mutant (Hrd1p C399S) was used (Bordallo and Wolf, 1999),Cell 158, 1375–1388, Sepand little modification was seen in the
absence of Cue1p-c (Figure 2A; for purity
of Hrd1p C399S, see Figure S1C).
Efficient polyubiquitination was also
observed with sCPY* and sCPY*-DHFR
(shown for sCPY* in Figure S2A). The ex-
periments with sCPY* showed that the
glycosylated and nonglycosylated spe-
cies were equally modified. Most of the
polyubiquitin chains on sCPY* and CPY*
are linked through Lys48 in ubiquitin, as
indicated by the much shorter chains
generated with a Lys48Arg ubiquitin
mutant (Figure S2B). When ubiquitin
was replaced with methylated ubiquitin,
which permits the attachment of a singleubiquitin molecule but prevents the synthesis of ubiquitin chains,
several modified bands appeared, indicating that the substrates
were modified at several different Lys-residues (Figure S2B).
A purified cytoplasmic fragment of Hrd1p (Hrd1p-c) did not
ubiquitinate CPY* (Figure 2A, lane 14) or sCPY* (Figure S2A,
lane 12), even when added at 10-fold higher concentrations,
although it could generate polyubiquitin chains (Figure S2C).
Thus, substrate needs to bind to the membrane-embedded
domain of Hrd1p to become polyubiquitinated.tember 11, 2014 ª2014 Elsevier Inc. 1377
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Figure 2. Polyubiquitination by Hrd1p
(A) Time course of ubiquitination of CPY* labeled
with DyLight800. Some reactions were analyzed
after 60 min with the indicated components
omitted. Where indicated, wild-type Hrd1p
(100 nM) was replaced with 100 nM of an inactive
Hrd1p mutant (C399S) or 1 mM of the cytoplasmic
domain of Hrd1p (Hrd1p-c).
(B) Time course of autoubiquitination of Hrd1p
labeled with DyLight680.
(C) The time course of auto- and substrate-ubiq-
uitination was determined in parallel. The concen-
tration of labeled Hrd1p was kept constant,
whereas that of unlabeled Hrd1p was varied.
(D) The time course of autoubiquitination was
determined with 50 nM of labeled wild-type (WT)
Hrd1p or C399Smutant in the absence or presence
of a 10-fold excess of unlabeled WT Hrd1p (solid
and broken curves, respectively).
See also Figure S2.Autoubiquitination of Hrd1p
Hrd1p itself was also polyubiquitinated. To study Hrd1p autou-
biquitination in more detail, we attached, by sortase labeling,
a fluorescent dye to the C terminus of Hrd1p, allowing the
simultaneous detection of Hrd1p and substrate. Hrd1p poly-
ubiquitination was very efficient (Figure 2B). Experiments with
methylated ubiquitin showed that modification of Hrd1p occurs
at several different Lys residues and that Hrd1p molecules often
contain two ubiquitin chains (Figure S2C, last lane). Mass spec-
trometry confirmed the modification of several Lys residues (po-
sitions 126, 143, 282, 325, 387, 407, 511, 518, 539, 540, and
546), but replacement of single Lys residues with Arg did not
drastically reduce autoubiquitination (data not shown). Because
a Hrd1p mutant in which all 27 Lys residues were changed to
Arg did not express, we generated mutants, in which Lys resi-
dues were replaced in the transmembrane domain (residues
1–301), the RING finger domain (302–407), or the C-terminal
tail (408–551) (RKK, KRK, and KKR mutants, respectively).
The RKK had significantly reduced levels of both auto- and sub-
strate-ubiquitination, whereas the KKR mutant was specifically
affected in autoubiquitination (Figure S2D). The KRK mutant
showed an intermediate phenotype. In none of the mutants
was auto-ubiquitination completely abolished. The cytoplasmic
fragment of Hrd1p (Hrd1p-c) showed little or no autoubiquitina-
tion; much of Hrd1p-c remained unmodified, and no modified
protein was seen with methylated ubiquitin (Figure S2C).
Thus, the transmembrane domain is required for efficient
autoubiquitination.
Hrd1p seems to modify itself by an intramolecular reaction,
because the rate of Hrd1p polyubiquitination was independent
of the Hrd1p concentration, in contrast to substrate poly-
ubiquitination (Figure 2C). Furthermore, when wild-type Hrd1p
was mixed with an inactive Hrd1p mutant (Hrd1p C399S), only1378 Cell 158, 1375–1388, September 11, 2014 ª2014 Elsevier Inc.the wild-type, and not the mutant, was
modified (Figure 2D), even though the
two proteins bind each other (Figure S2E).
We found no conditions in which only
substrate ubiquitination was observed.For example, reducing the concentrations of Ubc7p or Cue1p-
c did not favor substrate- over automodification (Figure S2F).
Autoubiquitination was observed even under conditions in which
Hrd1p was saturated with substrate, although the rate was
somewhat reduced (Figure S2G). Thus, autoubiquitination of
Hrd1p appears to be an integral part of the polyubiquitination
reaction.
Polyubiquitinated Hrd1p Recruits the Cdc48p
ATPase Complex
Next, we tested whether Hrd1p polyubiquitination leads to
recruitment of the Cdc48p ATPase complex. We first separately
purified hexameric Cdc48p and a complex of the heterodimeric
cofactor Ufd1p/Npl4p from Escherichia coli (Figure S1C). The in-
dividual components assembled into the Cdc48p complex, as
shown by gel filtration (Figure S3A). Next, we treated beads con-
taining polyubiquitinated Hrd1p with Cdc48p in the presence or
absence of Ufd1p/Npl4p. Binding of Cdc48p was observed in
the presence of the cofactor at low or physiological salt concen-
trations (Figure 3A, lane 4 versus 1 and lane 9 versus 6), but not at
high-salt concentrations (lane 14). Ufd1p/Npl4p alone also
bound to ubiquitinated Hrd1p (lanes 2 and 7), indicating that
the cofactor is responsible for the recruitment of the Cdc48p
complex. When Hrd1p was not preincubated with the ubiquitina-
tion machinery, Cdc48p binding was drastically reduced (Fig-
ure 3C); the residual binding is likely due to purified Hrd1p
carrying some ubiquitin chains (shown by mass spectroscopy).
We also tested the role of Ubx2p, a protein that interacts with
Cdc48p and ubiquitin and is involved in ERAD (Neuber et al.,
2005; Schuberth and Buchberger, 2005). Full-length Ubx2p
with an N-terminal His-tag was purified in the detergent DMNG
by Ni-NTA chromatography, followed by gel filtration (Fig-
ure S1C). Ubx2p bound to ubiquitinated Hrd1p (Figure 3A, lanes
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Figure 3. Recruitment of Cdc48p to Ubiquitinated Hrd1p
(A) Bead-immobilized Hrd1p (1 mM) was ubiquitinated and incubated at different salt conditions with 2 mM of the indicated components (UN, Ufd1p/Npl4p) in the
presence of 250 mM ATPgS. The bound material was analyzed by SDS-PAGE and stained with IRDye Blue.
(B) As in (A), but bead-immobilized Hrd1p was modified with methylated ubiquitin.
(C) As in (A), but with nonubiquitinated Hrd1p.
See also Figure S3.3, 8, and 13), but not to unmodified Hrd1p (Figure 3C). Ubx2p
increased the binding affinity of the Cdc48p complex for polyu-
biquitinated Hrd1p, as indicated by the resistance of the interac-
tion to high-salt concentrations (Figure 3A, lane 15). In contrast
to Cdc48p complex alone, a complex with Ubx2p also bound
to monoubiquitinated Hrd1p generated with methylated ubiqui-
tin (Figure 3B, lanes 5 and 10). Even in the presence of Ubx2p,
the Ufd1p/Npl4p complex was essential for the recruitment of
Cdc48p (data not shown), suggesting that Ubx2p interacts
only weakly with Cdc48p itself. Indeed, gel filtration showed
an increased association of Ubx2p’s UBX domain (Ubx2p-c)
with Cdc48p in the presence of Ufd1p/Npl4p (Figures S3A and
S3B; see Figure S1C for purity of the protein). A similar hierarchy
has been observed with another UBX domain containing protein
(Ha¨nzelmann et al., 2011). Taken together, our results show that
polyubiquitinated Hrd1p recruits the Cdc48p complex. Ubx2p
stimulates or stabilizes the association but is not essential,
consistent with in vivo data (Neuber et al., 2005; Schuberth
and Buchberger, 2005).
Cdc48p-Dependent Substrate Release from Hrd1p
Next, we tested whether Cdc48p can release substrate bound to
Hrd1p. We first formed a complex between bead-immobilized
SBP-tagged Hrd1p and fluorescently labeled CPY* and then
incubated the beads with the ubiquitination machinery. After
removal of the ubiquitination machinery, the beads were incu-
bated with Cdc48p in the presence of Ufd1p/Npl4p and ATP.
About 50% of polyubiquitinated CPY* was released from theCbeads (Figure 4A, lane 6; quantification in Figure 4B). No release
above background was seen if ATP was depleted with hexoki-
nase/glucose (Hk/G) (Figure 4A, lane 7) or if Cdc48p or Ufd1/
Npl4p were omitted (lanes 4 and 5). Similar results were obtained
with sCPY* (Figures S4A and S4B).
We noticed that nonubiquitinated CPY* and sCPY* were also
released from Hrd1p by Cdc48p activity (Figures 4A and S4A).
This was confirmed in experiments in which CPY* was added af-
ter the ubiquitination reaction, so that only Hrd1p was modified
(Figure 4C; quantification in Figure 4D). SomeCPY*was released
from the beads without Cdc48p action, likely because ubiquiti-
nated Hrd1p is partially dissociating from the beads. No release
was seen for substrate bound to nonubiquitinated Hrd1p (Fig-
ures 4C and 4D). Similar results were obtained with sCPY* and
sCPY*-DHFR (Figures S4C and S4D), although more sponta-
neous release was seen with sCPY*, consistent with its reduced
binding affinity for Hrd1p. Together, these data indicate that the
Cdc48p ATPase complex is first recruited to polyubiquitinated
Hrd1p and then uses ATP hydrolysis to release both polyubiqui-
tinated and nonubiquitinated substrate from Hrd1p.
To test whether autoubiquitination at a specific site is required
for the release of nonubiquitinated substrate, we employed Lys
mutants of Hrd1p (Figure 4E). The release was significantly
reducedwith the RKK and KRKmutants but was even stimulated
with the KKR mutant. Thus, ubiquitin chains attached to either
one of the N-terminal regions, but not the C-terminal tail, are
required for efficient release of nonmodified substrate from
Hrd1p.ell 158, 1375–1388, September 11, 2014 ª2014 Elsevier Inc. 1379
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Figure 4. Substrate Release from Hrd1p by
Cdc48p ATPase
(A) A bead-immobilized complex of 500 nM SBP-
tagged Hrd1p and 100 nM fluorescently labeled
CPY* was incubated with the ubiquitination ma-
chinery. The beads were washed and incubated
with 100 nM Cdc48p and ATP in the absence or
presence of 100 nM Ufd1/Npl4p (UN) complex or
with UN alone. Where indicated, ATP was depleted
with hexokinase/glucose (Hk/G). The released ma-
terial was analyzed by SDS-PAGE and fluorescence
scanning. The total releasable amount of CPY* was
determined by incubating the beads with biotin.
(B) Quantification (means and SD) of released pol-
yubiquitinated CPY* determined from four experi-
ments as shown in (A). The released fraction is ex-
pressed relative to the total releasable material.
(C) Bead-immobilized SBP-tagged Hrd1p was
ubiquitinated (Ub-Hrd1p) for 1 hr. The beads were
washed, incubated with fluorescently labeled CPY*,
and treated as in (A). The lower panel shows the
same experiment with nonubiquitinated Hrd1p
(non-Ub-Hrd1p).
(D) Quantification (means and SD) of released
nonubiquitinated CPY* determined from four
experiments as shown in (C) (released from Ub-
Hrd1p, black columns; released from non-Ub-
Hrd1p, gray columns).
(E) Immobilized Hrd1p mutants with Lys-to-Arg
mutations in three different regions were ubiquiti-
nated for 30min, and Cdc48p-dependent release of
unmodified CPY* was tested as in (C). Shown are
means and SD of three experiments.
(F) Bead-immobilized Hrd1p was incubated with
untagged, fluorescently labeled Hrd1p. After ubiq-
uitination and washing, the beads were incubated
with the indicated components. The material
released from the beads was analyzed by SDS-
PAGE and fluorescence scanning.
(G) Quantification of three experiments performed
as in (E) (means and SD).
See also Figure S4.Next, we tested whether substrate release from Hrd1p is
mediated by the dissociation of Hrd1p oligomers. Streptavidin
beads were incubated with a mixture of Hrd1p-SBP and fluores-
cently labeled Hrd1p, so that labeled Hrd1p was bound to the
beads through Hrd1p-SBP. After polyubiquitination, the addition
of Cdc48p, Ufd1p/Npl4p, and ATP led to the dissociation of
80% of labeled polyubiquitinated Hrd1p (Figure 4F, lane 4; Fig-
ure 4G). Significantly less Hrd1p was released when ATP was
depleted with Hk/G or in the absence of Ufd1/Npl4p (Figures
4F, lanes 7 and 3; Figure 4G). These results indicate that the1380 Cell 158, 1375–1388, September 11, 2014 ª2014 Elsevier Inc.Cdc48p ATPase causes the dissociation
of polyubiquitinated Hrd1p oligomers.
As monomers bind substrate more
weakly (Figure 1G), this may explain the
release of substrate from Hrd1p, particu-
larly the release of nonubiquitinated sub-
strate, which itself cannot interact with
the Cdc48p complex. Cdc48p complexadded directly to the ubiquitination reaction reduced substrate
modification (Figure S4E), consistent with increased substrate
release. Autoubiquitination was not affected (Figure S4E), as ex-
pected from an intramolecular reaction (Figure 2D).
Involvement of the DUB Enzyme Otu1p in ERAD
Because the DUB enzyme Yod1p had been implicated in ERAD-
L (Ernst et al., 2009; Rumpf and Jentsch, 2006), we next investi-
gated the role of its yeast homolog Otu1p. Expression of an
inactive Otu1p mutant (Otu1p C120S), but not wild-type Otu1p,
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Figure 5. Cdc48p-Dependent Function of Otu1p In Vivo
(A) The degradation of a fusion of sCPY* with DHFR and a hemagglutinin (HA) tag (sCPY*-DHFR-HA) was tested in S. cerevisiae. The cells were transformed with
an empty vector or plasmids expressing FLAG-taggedwild-type or mutant Otu1p (Otu1p [C120S]) from aGal1 promoter. Where indicated, Otu1p variants lacking
their UBX domains were expressed instead. The samples were analyzed at different time points after addition of cycloheximide (chx) by SDS-PAGE and
immunoblotting with anti-HA and anti-FLAG antibodies. Loading controls were performed with Kar2p antibodies.
(B) Quantification of two experiments as in (A) (means and SD).
(C) As in (A) but following simultaneously the degradation of Erg1p and Deg1-LacZ with antibodies to the endogenous protein and to LacZ, respectively.
(D) Quantification of three experiments as in (C) (means and SD).
(E) The degradation of sCPY*-DHFR-HA was analyzed in cells lacking Otu1p and WT cells. Cells lacking Hrd1p were analyzed in parallel.
(F) Quantification of the experiment in (E).
See also Figure S5.strongly inhibited the degradation of the ERAD-L substrate
sCPY*-DHFR in S. cerevisiae cells (Figures 5A and 5B). The
Hrd1p levels were not greatly affected (Figure S5A). The degra-
dation of the ERAD-C substrate Erg1p was also inhibited (Fig-
ures 5C and 5D). Although Otu1p C120S expression inhibited
cell growth (Figure S5B), the effect on ERAD occurred in viable
cells, as demonstrated by the degradation of the cytosolic pro-
teasome substrate Deg1-LacZ (Figures 5C and 5D; data not
shown). As Deg1-LacZ degradation does not depend on
Cdc48p (Ravid et al., 2006), the Otu1p mutant seems to affect
only Cdc48p-dependent substrates. Indeed, deletion of the
Cdc48p-interacting UBX domain from Otu1p C120S greatly
reduced the inhibition (Figures 5A and 5B). Otu1p does notCseem to be the only DUB involved in ERAD, as a yeast strain lack-
ing Otu1p did not show ERAD-L defects (Figures 5E and 5F).
To analyze Otu1p in vitro, we expressed a His-tagged version
and purified it by Ni-affinity chromatography and gel filtration
(Figure S1C). Otu1p deubiquitinated modified fluorescently
labeled Hrd1p or CPY* efficiently only when Cdc48p and
Ufd1/Npl4p were present (Figures 6A–6C). Much less deubiqui-
tination was observed with Otu1p and Cdc48p alone, even
though they interact with one another, consistent with the
slow reaction previously observed (Rumpf and Jentsch, 2006).
Addition of Ufd1p/Npl4p alone significantly accelerated Otu1p
action (Figures 6A and 6B), in contrast to another ubiquitin-
binding protein (Rad23p) (data not shown). As expected, theell 158, 1375–1388, September 11, 2014 ª2014 Elsevier Inc. 1381
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Figure 6. Cdc48p-Dependent In Vitro Deubiquitination by Otu1p
(A) Bead-immobilized fluorescently labeled Hrd1p-SBP was incubated with the ubiquitination machinery. After washing, Hrd1p was eluted from the beads with
biotin and incubatedwith the indicated components (Ufd1/Npl4p; UN) for different time periods in the presence of ATP. Hrd1pwas in a 30-fold excess over Otu1p,
whereas all other components were about equimolar to Hrd1p. The samples were analyzed by SDS-PAGE and fluorescence scanning.
(legend continued on next page)
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Otu1p C120S mutant was inactive (Figure 6B). ATP hydrolysis
by Cdc48p stimulated deubiquitination by Otu1p, as shown
with an ATPase-deficient Cdc48p mutant (E588Q mutation)
and by ATP depletion with Hk/G (Figure 6B). Otu1p needs to
bind to the Cdc48p complex, as deletion of the UBX domain
drastically reduced DUB activity (Figure 6B). Similar results
were obtained with polyubiquitinated Hrd1p containing fluores-
cently labeled ubiquitin, instead of labeled Hrd1p (Figures S6A
and S6B). Otu1p removes short ubiquitin chains, rather than
individual ubiquitin molecules, and it does not completely deu-
biquitinate Hrd1p.
We found that Otu1p inhibited Cdc48p-dependent substrate
release by only 50%, even at high concentrations (data not
shown). Thus, Cdc48p often functions before Otu1p has a
chance to make the ubiquitin chains too short. On the other
hand, experiments with bead-immobilized polyubiquitinated
Hrd1p showed that extended incubation with Otu1p causes
most of the Cdc48p complex to eventually dissociate, both in
the absence or presence of ATP hydrolysis (Figure 6D; see su-
pernatants in lanes 7 and 3 versus those in lanes 6 and 1). The
inactive Otu1p C120S mutant had no effect. These data suggest
that Cdc48p function generally precedes Otu1p-mediated trim-
ming of the ubiquitin chains. Interestingly, Ubx2p inhibited
Cdc48p-dependent deubiquitination (Figure 6C), suggesting
that in vivo it could help to prevent the premature function of
Otu1p at the membrane.
Cdc48p-Dependent Protein Extraction from
Reconstituted Proteoliposomes
Finally, we tested whether the ERAD-L reactions would also
occur with Hrd1p reconstituted into proteoliposomes. Proteoli-
posomes were generated by detergent removal from a mixture
of purified Hrd1p and synthetic phospholipids, both in DMNG.
We also added a fluorescently labeled lipid (Texas Red phospha-
tidyl ethanolamine; TR-PE) prior to detergent removal. The re-
constituted vesicles, including labeled Hrd1p and lipid, floated
in a Nycodenz-step gradient (Figure 7A). The majority of Hrd1p
was found in the second fraction from the top, whereas much
of the lipid floated all theway to the top, indicating that some ves-
icles contain no protein and others Hrd1p oligomers. Most Hrd1p
molecules have their cytoplasmic domain exposed to the
outside of the vesicles, as demonstrated by the accessibility of
a C-terminal TEV cleavage site to the TEV protease (Figure 7B).
When labeled Hrd1p-containing proteoliposomes or protein-free
liposomes were mixed with fluorescently labeled CPY*, only
10% of substrate floated with the proteoliposomes (Figure 7C,
blue and black columns). Thus, substrate binds only weakly to
the cytoplasmic side of membrane-incorporated Hrd1p. Next,
we coreconstituted labeled CPY* and Hrd1p into vesicles. Flota-(B) Quantification of experiments performed as in (A). The disappearance of the lo
of three experiments). ATP was depleted with hexokinase/glucose (Hk/G). Where
mutant lacking the UBX domain was used.
(C) Bead-immobilized complexes of Hrd1p-SBP and CPY*, labeled with different fl
and CPY* was followed in parallel (solid and broken lines, respectively). Shown a
(D) Bead-immobilized ubiquitinated Hrd1-SBP was incubated with Cdc48p comp
with the indicated components. Supernatants and beads were analyzed by SDS
See also Figure S6.
Ction experiments showed that essentially all substrate comi-
grated with the reconstituted vesicles (Figure 7C; red columns).
The efficiency of coflotation correlated with the binding affinity of
substrate for Hrd1p in detergent; 40% were found for sCPY*
(data not shown), whereas wild-type CPY did not float at all (Fig-
ure 7C). Addition of trypsin to the proteoliposomes showed that
labeled CPY* was not protected by the lipid bilayer (Figure 7D),
indicating that the substrate is bound to the transmembrane
domain of Hrd1p with segment(s) exposed to the outside of
the vesicles.
Next, we incubated proteoliposomes containing labeled
Hrd1p and substrate with the ubiquitination machinery. About
80% of both Hrd1p and CPY* were polyubiquitinated (Figures
7E and 7F). Wild-type CPY remained largely unmodifed. About
90% of polyubquitinated Hrd1p and CPY* floated with the vesi-
cles in a Nycodenz gradient (Figure 7G; lanes 1–6), indicating
that polyubiquitination alone does not extract proteins from the
membrane. Ubiquitination increased the density of the vesicles.
Unmodified Hrd1p and CPY* also shifted their position in the
gradient, consistent with the observation that the vesicles
contain multiple Hrd1p molecules, some of which become
polyubiquitinated.
Finally, we tested whether polyubiquitinated Hrd1p and CPY*
molecules are extracted from the membrane by the Cdc48p
complex. Proteoliposomes containing fluorescently labeled
Hrd1p and CPY* were incubated with the ubiquitination machin-
ery, followed by the addition of Cdc48p and Ufd1p/Npl4p. The
sample was then subjected to flotation in a Nycodenz gradient.
Approximately 20%–25% of CPY* and up to 35% of Hrd1p
were found in the bottom fractions (Figures 7G, lanes 7–12;
quantification in Figure 7H), indicating that they were no longer
associated with the liposomes. Longer incubation times or
higher Cdc48p complex concentrations did not increase the
efficiency of membrane extraction (Figures S7A and S7B). No
membrane extraction was observed in the absence of ubiquiti-
nation, when Cdc48p or Ufd1p/Npl4p were omitted, when an
ATPase-defective Cdc48p mutant was used, or when ATP was
depleted with Hk/G (Figure 7H). The extracted Hrd1p and
CPY* proteins carried relatively short ubiquitin chains (Figure 7G);
most of the longer chains remained in the floated fractions, sug-
gesting that they are poor substrates for the Cdc48p complex.
Otu1p addition inhibited the membrane extraction of polyubi-
quitinated proteins to a maximum of 50% (Figures S7C and
S7D), similar to the effect of Otu1p on substrate release from
Hrd1p in detergent (data not shown). The inactive Otu1p
C120S mutant had no effect on membrane extraction, even
when added in a 10-fold excess over Cdc48p (Figure S7D), sug-
gesting that its effect in vivo (Figures 5A and 5B) is caused at a
step following substrate release into the cytosol.ngest ubiquitin chains was quantified under different conditions (means and SD
indicated, an ATPase-defective Cdc48p mutant (Cdc48p E588Q) or an Otu1p
uorescent dyes, were treated as in (A). The deubiquitination of modified Hrd1p
re the means and SD of three experiments.
lex in the presence of ATPgS. After washing, the beads were incubated for 1 hr
-PAGE and Coomassie staining.
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Figure 7. Membrane Extraction of Polyubiquitinated Proteins by Cdc48p
(A) Proteoliposomes containing fluorescently labeled Hrd1p-SBP and Texas red-labeled phosphatidyl ethanolamine (TR-PE) were subjected to flotation in a
Nycodenz gradient. Fractionswere collected from the top and analyzed by SDS-PAGE and fluorescence scanning of the gel. The lipid content of the fractionswas
determined by absorbance at 590 nm.
(B) Proteoliposomes containing Hrd1p-SBP with a TEV cleavage site at the C terminus were treated with TEV protease in the absence or presence of DMNG. The
samples were analyzed by SDS-PAGE and staining with Coomassie blue.
(C) Fluorescently labeled CPY* was incubated with either protein-free liposomes or proteoliposomes containing Hrd1p, or it was coreconstituted with Hrd1p into
vesicles (black, light blue, and red bars, respectively). The sampleswere subjected to flotation in a Nycodenz gradient, and fractionswere analyzed by SDS-PAGE
and fluorescence scanning. Wild-type CPY was used as a control.
(D) Proteoliposomes containing Hrd1p and labeled CPY* were incubated with trypsin in the absence or presence of DMNG. The samples were analyzed by SDS-
PAGE and fluorescence scanning.
(legend continued on next page)
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All three Hrd1p mutants with Lys mutations showed reduced
extraction of polyubiquitinated Hrd1p from the membrane (Fig-
ure 7I), consistent with their lowered level of modification (Fig-
ure S2D). The site of modification does not seem to be important,
in contrast to the release of unmodified substrate from poly-
ubiquitinated Hrd1 in detergent (Figure 4E). Although less pro-
nounced, the site of modification also affected the extraction
of polyubiquitinated substrate from Hrd1p-containing proteoli-
posomes, as the RKK mutant had a significantly stronger effect
on substrate extraction than on Hrd1p extraction (Figure 7I). The
KKRmutant was not affected inmembrane extraction of the sub-
strate (Figure 7I), indicating that modification of the C-terminal
tail is not required for substrate release fromHrd1p and suggest-
ing that substrate is not obligatorily extracted as a complex with
Hrd1p.
DISCUSSION
We have reproduced key steps of ERAD-L with purified protein
components, both in detergent and in reconstituted proteolipo-
somes. Our minimal in vitro system mimics essential aspects
of ERAD-L in vivo when Hrd1p is overexpressed (basic ERAD-
L). In both systems, glycosylated and nonglycosylatedmisfolded
proteins serve as substrates for Hrd1p, and Hrd1p itself is poly-
ubiquitinated and extracted from the membrane. Because
Hrd1p appears to be the only membrane component required
for a basic ERAD-L reaction in vivo, and because Hrd1p is suffi-
cient for the binding and membrane extraction of misfolded
proteins in vitro, it is likely to form a channel for the transport of
misfolded proteins through the ER membrane.
Our in vitro system allowed us to break down the basic ERAD-
L process into individual steps. First, Hrd1p binds unfolded poly-
peptides through its membrane-spanning domain. Next, both
Hrd1p and substrate are polyubiquitinated, resulting in the
recruitment of the Cdc48p ATPase complex, a process medi-
ated by the cofactor Ufd1p/Npl4p and facilitated by the adaptor
protein Ubx2p. Then the polyubiquitinated proteins are ex-
tracted from the membrane by the Cdc48p complex in an ATP
hydrolysis-dependent reaction. Finally, Otu1p trims the polyubi-
quitin chains in a Cdc48p complex-dependent manner, resulting
in the dissociation of the Cdc48p complex from substrate.
In basic ERAD-L, substrates are exclusively selected by
Hrd1p. We show that Hrd1p in detergent discriminates folded
from unfolded polypeptides. Hrd1p uses its hydrophobic TM
segments to bind unfolded polypeptide segments. Oligomeric
Hrd1p may provide more TMs for substrate interaction than(E) Proteoliposomes were generated by coreconstitution of Hrd1p with either C
rophores. The vesicles were incubated with the ubiquitination machinery for differ
scanning. For Hrd1p, the gel was cropped to only show the disappearance of un
(F) The disappearance of unmodified protein in (D) was quantitated. Solid and br
(G) Fluorescently labeled Hrd1p and CPY* were coreconstituted into proteoliposo
by incubation in the absence or presence of the Cdc48p complex (Cdc48p/UN). Th
SDS-PAGE and fluorescence scanning.
(H) Experiments as in (G) were quantified by determining the total fluorescence in t
total fluorescence in the gradient (mean and SD of at least three experiments). Whe
deficient Cdc48p mutant (Cdc48p E588Q) was used.
(I) As in (G) but with Hrd1p mutants carrying Lys to Arg mutations in three differe
See also Figure S7.
Cdoes monomeric Hrd1p, explaining why it has a higher affinity.
Hrd1p does not interact with all hydrophobic polypeptide seg-
ments, because it does not bind Ubx2p (Figure S3C) or a frag-
ment of Usa1p lacking the N-terminal cytoplasmic interaction
domain (data not shown). Perhaps, a loosely folded polypeptide
structure is also required for substrate recognition. It seems
likely that several TMs in Hrd1p interact with an unfolded poly-
peptide chain because mutations scattered throughout the
membrane-embedded domain of Hrd1p affect different sub-
strates to varying degrees (Sato et al., 2009). Although some
substrate interaction may be caused simply by the hydrophobic-
ity of the TMs, the membrane-embedded domain of Hrd1p must
have unique properties, as it needs to be folded, and only little
substrate interaction is seen with purified Usa1p containing
two TM segments (data not shown).
Insertion of a polypeptide loop into the Hrd1p channel could
be the first step in the actual retrotranslocation process. Such
a model would be analogous to loop insertion of a signal
sequence-containing polypeptide into the Sec61/SecY channel
during forward translocation (Park and Rapoport, 2012). In
both cases, a substrate segment would reach the other side of
the membrane and the binding of a hydrophobic region to the
channel would provide the driving force for polypeptide chain
insertion. Our experiments show that a misfolded substrate
coreconstituted with Hrd1p indeed exposes a segment to the
outside of vesicles. As expected, substrate does not bind to
Hrd1p from the cytoplasmic side when added after reconstitu-
tion. However, it remains to be shown that reconstituted Hrd1p
can bind substrate on the luminal side of the membrane, as sug-
gested by experiments in intact yeast cells overexpressing
Hrd1p (Carvalho et al., 2010). A system in which the starting pro-
teoliposomes contain only Hrd1p or substrate and are subse-
quently fused will also address whether actual retrotranslocation
can be reproduced with the purified components.
Similar to forward translocation, a polypeptide chain may be
able to slide back and forth in a Hrd1p channel, but there has to
be energy input to achieve net movement into the cytosol. One
possibility is that the attachment of polyubiquitin chains to the
substrate would bias polypeptide sliding, providing a ratcheting
mechanism for translocation. However, polyubiquitination alone
is insufficient to completely move a polypeptide chain from the
ER membrane into the cytosol, as shown both in vivo (Flierman
et al., 2003) and by our in vitro experiments; this requires the
function of the Cdc48p complex as well. In fact, our data indi-
cate that the Cdc48p complex is sufficient to move polyubiqui-
tinated proteins into the cytosol, although other cytosolicPY* or wild-type CPY. Hrd1p and substrate were labeled with different fluo-
ent time periods, and samples were analyzed by SDS-PAGE and fluorescence
modified protein.
oken lines show the modification of substrate and Hrd1p, respectively.
mes. The vesicles were incubated with the ubiquitination machinery, followed
e vesicles were floated in a Nycodenz gradient, and fractions were analyzed by
he bottom two fractions (material released from the vesicles) as a fraction of the
re indicated, ATPwas depleted with hexokinase/glucose (Hk/G) or an ATPase-
nt regions. Quantification of three experiments was done as in (H).
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factors could be stimulatory. Current models assume that the
Cdc48p-binding polyubiquitin chains need to be attached to
the substrate, but our data raise the possibility that the crucial
modification is on Hrd1p itself. We show that Cdc48p releases
unmodified substrate from polyubiquitinated Hrd1p in deter-
gent, probably by disassembling Hrd1p oligomers into smaller
assemblies that have a lower affinity for substrate. Indeed, for
Cdc48p’s segregase activity, it is not necessary that the ubiq-
uitin chains are attached to the protein extracted from the
membrane, as shown for the generation of the transcription
factors Mga2p and Spt23p. Here, Cdc48p action releases an
unmodified polypeptide (the p90 fragment) into the cytosol by
acting on polyubiquitin chains attached to an associated mem-
brane-anchored protein (the p120 precursor) (Shcherbik and
Haines, 2007). Autoubiquitination of Hrd1p followed by
Cdc48p function could provide the driving force for retrotrans-
location by allowing substrate segments to move through the
membrane by multiple rounds of binding to and release from
Hrd1p. Such a model does not exclude a role for substrate
ubiquitination, which could determine directionality of polypep-
tide movement by a ratcheting mechanism or by interaction
with the Cdc48p complex.
Amodel in which autoubiquitination of Hrd1p is a crucial modi-
fication event would be consistent with studies showing that
substrates, in which all Lys residues are removed, continue to
be degraded; in these cases, the ubiquitination machinery was
still required, suggesting that a protein other than the substrate
is ubiquitinated (Hassink et al., 2006; Wang et al., 2013; Yu and
Kopito, 1999). There are also ERAD-L substrates, such as pre-
pro-a-factor and cholera toxin, which are never ubiquitinated
and whose retrotranslocation can be blocked with a dominant-
negative DUB (Bernardi et al., 2013), again indicating ubiquitina-
tion of another component. Protease-protection studies showed
that ubiquitination is required to expose a substrate segment to
the cytosol (Jarosch et al., 2002), and photocrosslinking demon-
strated that the ubiquitination activity of Hrd1p and Cdc48p ac-
tion are needed for an early Hrd1p-substrate interaction on the
luminal side of the membrane (Carvalho et al., 2010). These re-
sults suggest that ubiquitination by Hrd1p of a component other
than substrate is crucial for ERAD-L.
Although a role for autoubiquitination of Hrd1p is attractive, it
is difficult to exclude that at least some Hrd1pmodification is the
result of a nonspecific side reaction that has been observed with
other ligases. Indeed, we found that ubiquitination of the C-ter-
minal tail of Hrd1p has no effect on substrate modification and
release. There is also little evidence that Hrd1p is polyubiquiti-
nated in wild-type yeast cells. It is therefore possible that
Hrd1p modification and Cdc48p-dependent extraction serve to
regulate Hrd1p levels in the membrane. However, because au-
toubiquitination occurs in an intramolecular reaction, our results
argue that Hrd1p molecules do not recognize each other as
unfolded ERAD-M substrates. Regardless of whether autoubi-
quitination is required for ERAD or as a regulatory mechanism,
it is minimized in wild-type cells.
Our in vitro results faithfully recapitulate what is observed
in vivo in Hrd1p-overexpressing yeast cells. However, they do
not recapitulate substrate selection as seen in wild-type cells,
where the additional ERAD components Yos9p, Hrd3p, and1386 Cell 158, 1375–1388, September 11, 2014 ª2014 Elsevier Inc.Der1p ensure that only genuine substrates are degraded (Denic
et al., 2006; Gauss et al., 2006; Mehnert et al., 2014; Xie and Ng,
2010). Our results indicate that recognition of an unfolded poly-
peptide by Hrd1p is the last checkpoint before substrate
is committed to retrotranslocation and degradation. This may
explain why bypassing all upstream steps in Hrd1p-overex-
pressing cells slows, but does not prevent, cell growth. In addi-
tion, Hrd1p may provide the main checkpoint for nonglycosy-
lated ERAD substrates. The additional ERAD components may
also minimize excessive autoubiquitination and membrane
extraction of Hrd1p. Hrd3p has a particularly important role, as
in its absence, Hrd1p is poly-ubiquitinated and degraded (Gard-
ner et al., 2000; Plemper et al., 1999). Perhaps, Hrd3p is re-
gulating autoubiquitination of Hrd1p in response to substrate
binding.
Our results support the idea that DUBs, specifically Otu1p,
play a role in ERAD. We show that Otu1p is only activated after
recruitment by the Cdc48p complex. This ensures that poly-
ubiquitination, Cdc48p recruitment, and deubiquitination occur
in a sequential manner. Our data suggest that Cdc48p-mediated
membrane extraction precedes Otu1p function, so that most
substrate deubiquitination occurs in the cytosol. Ubx2p could
help to prevent premature deubiquitination at the membrane
by competing with Otu1p for Cdc48p binding. The kinetic delay
would guarantee that Otu1p does not interfere with Cdc48p’s
function as a segregase. The sequential action of Cdc48p and
Otu1p would be further enhanced by the ubiquitin ligase Hrd1p
counteracting deubiquitination at the membrane, but not in the
cytosol. A function of Otu1p downstreamof Cdc48p’s segregase
activity explains why overexpression of wild-type Otu1p does
not affect ERAD in vivo. The inactive Otu1p mutant would inhibit
by interacting with polyubiquitin chains bound to the Cdc48p
complex, preventing the dissociation of Ufd1p/Npl4p and block-
ing the access of other DUBs. Indeed, expression of the equiva-
lent Yod1pmutant in mammalian cells leads to the accumulation
of ubiquitinated substrate bound to the ATPase complex (Ernst
et al., 2009). The inactive Otu1p mutant does not inhibit mem-
brane extraction in vitro, because there is probably no need for
the Cdc48p complex to be recycled. Otu1p/Yod1p probably
function not only in ERAD but also in other processes involving
the Cdc48p/Ufd1p/Npl4p complex.
Finally, our results suggest that ERAD-L proceeds through an
intermediate in which the substrate is bound to the membrane-
embedded domain of Hrd1p, a situation that resembles the
recognition of an ERAD-M substrate. Thus, ERAD-M substrates
may enter the same process at a later stage, explaining why the
same ubiquitin ligase (Hrd1p) is involved and why ERAD-M re-
quires only a subset of the ERAD-L components. Many other
ubiquitin ligases, such as Doa10p involved in ERAD-C, are also
multispanning membrane proteins. As proposed previously for
Doa10p (Swanson et al., 2001), the membrane-spanning do-
mains may serve as conduits for polypeptides through the
membrane.EXPERIMENTAL PROCEDURES
Details of protein purifications and experimental procedures are described in
the Extended Experimental Procedures.
Protein Expression and Purification
All proteins are from S. cerevisiae. Uba1p and Ubx2p and the substrates CPY*,
sCPY*, sCPY*-DHFR, and CPY, as well as Hrd1p and its variants, were
expressed in S. cerevisiae under the Gal1 promoter. All other proteins were ex-
pressed in E. coli strain BL21 DE3 RIPL. The membrane proteins Ubx2p and
Hrd1p and its variants were solubilized in DMNG. ERAD substrates were ex-
tracted from a crude membrane fraction with urea. Hrd1p and its variants
were first purified by streptavidin affinity chromatography utilizing a C-terminal
streptavidin-binding peptide (SBP) tag, followed by gel filtration. All other
proteins were purified as His-tagged variants by Ni-affinity chromatography,
followed by ion-exchange chromatography and/or gel filtration. Unless noted
otherwise, the tags were proteolytically removed.
Labeling with Fluorescent Dyes
The substrates sCPY*, sCPY*-DHFR, sCPY*-GFP, DHFR, and GFP were
labeled at a C terminally attached Cys residue with DyLight 800 maleimide.
CPY* and CPY were labeled with a N-hydroxy-succinimidyl ester of DyLight
800. Hrd1p was labeled using the sortase technique.
Ubiquitination Assays
All ubiquitination assays were performed at 30C. Unless indicated otherwise,
the concentrations of the components of the ubiquitination machinery were
100 nMUba1p, 1 mMUbc7p, 1 mMCue1p-c, 100 nMHrd1p, 100 nM substrate,
100 mM ubiquitin, and 2.5 mM ATP.
Binding and Release Experiments
All binding experiments were performed at room temperature with Hrd1p
immobilized on magnetic streptavidin beads via its C-terminal SBP-tag. Un-
bound and bound fluorescent material was analyzed by SDS-PAGE and
fluorescence scanning of the gel in an Odyssey scanner (Li-COR). Binding of
substrates or Cdc48p to ubiquitinated Hrd1p was tested by first immobilizing
Hrd1p-SBP on beads at room temperature for 1 hr and then adding the ubiq-
uitination machinery.
Reconstitution into Proteoliposomes and Density Gradients
For reconstitution of Hrd1p, protein-free liposomes (final lipid concentration
10 mM, containing 0.5 mol% Texas Red-labeled phosphatidyl ethanolamine)
were mixed with DMNG (15 mM) and Hrd1p (2 mM) (and optionally with sub-
strate [0.5 mM]) and incubated for 1 hr at room temperature. This mixture
was applied to detergent-removal spin columns (Pierce).
In Vivo ERAD-Substrate Degradation Experiments
Cycloheximide shutoff experiments were performed essentially as described
previously (Carvalho et al., 2010).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cell.2014.07.050.
ACKNOWLEDGMENTS
We thank Robert Oliete for preliminary experiments, Ryan Baldridge, Alexan-
dra Boye-Doe, Angelyn Larkin, Nicholas Bodnar, and Stefan Schoebel for help
with some in vitro experiments, and Randy King, Ryan Baldridge, and Adrian
Salic for their critical reading of the manuscript. A.S. is supported by an Otto
Hahn Fellowship of the Max Planck Society; A.R. is supported by a ‘‘La Caixa’’
graduate fellowship; and T.A.R. is supported by an NIH grant (GM052586).
T.A.R. is a Howard Hughes Medical Institute Investigator.
Received: January 7, 2014
Revised: June 6, 2014
Accepted: July 2, 2014
Published: September 11, 2014CREFERENCES
Bagola, K., Mehnert, M., Jarosch, E., and Sommer, T. (2011). Protein disloca-
tion from the ER. Biochim. Biophys. Acta 1808, 925–936.
Bays, N.W., Gardner, R.G., Seelig, L.P., Joazeiro, C.A., and Hampton, R.Y.
(2001a). Hrd1p/Der3p is a membrane-anchored ubiquitin ligase required for
ER-associated degradation. Nat. Cell Biol. 3, 24–29.
Bays, N.W., Wilhovsky, S.K., Goradia, A., Hodgkiss-Harlow, K., and Hampton,
R.Y. (2001b). HRD4/NPL4 is required for the proteasomal processing of ubiq-
uitinated ER proteins. Mol. Biol. Cell 12, 4114–4128.
Bernardi, K.M., Williams, J.M., Inoue, T., Schultz, A., and Tsai, B. (2013). A
deubiquitinase negatively regulates retro-translocation of nonubiquitinated
substrates. Mol. Biol. Cell 24, 3545–3556.
Biederer, T., Volkwein, C., and Sommer, T. (1997). Role of Cue1p in ubiquitina-
tion and degradation at the ER surface. Science 278, 1806–1809.
Bordallo, J., and Wolf, D.H. (1999). A RING-H2 finger motif is essential for the
function of Der3/Hrd1 in endoplasmic reticulum associated protein degrada-
tion in the yeast Saccharomyces cerevisiae. FEBS Lett. 448, 244–248.
Bordallo, J., Plemper, R.K., Finger, A., and Wolf, D.H. (1998). Der3p/Hrd1p is
required for endoplasmic reticulum-associated degradation of misfolded
lumenal and integral membrane proteins. Mol. Biol. Cell 9, 209–222.
Brodsky, J.L. (2012). Cleaning up: ER-associated degradation to the rescue.
Cell 151, 1163–1167.
Carvalho, P., Goder, V., and Rapoport, T.A. (2006). Distinct ubiquitin-ligase
complexes define convergent pathways for the degradation of ER proteins.
Cell 126, 361–373.
Carvalho, P., Stanley, A.M., and Rapoport, T.A. (2010). Retrotranslocation of
a misfolded luminal ER protein by the ubiquitin-ligase Hrd1p. Cell 143,
579–591.
Denic, V., Quan, E.M., and Weissman, J.S. (2006). A luminal surveillance
complex that selects misfolded glycoproteins for ER-associated degradation.
Cell 126, 349–359.
Ernst, R., Mueller, B., Ploegh, H.L., and Schlieker, C. (2009). The otubain YOD1
is a deubiquitinating enzyme that associates with p97 to facilitate protein dislo-
cation from the ER. Mol. Cell 36, 28–38.
Finger, A., Knop, M., and Wolf, D.H. (1993). Analysis of two mutated vacuolar
proteins reveals a degradation pathway in the endoplasmic reticulum or a
related compartment of yeast. Eur. J. Biochem. 218, 565–574.
Flierman, D., Ye, Y., Dai, M., Chau, V., and Rapoport, T.A. (2003). Polyubiquitin
serves as a recognition signal, rather than a ratcheting molecule, during retro-
translocation of proteins across the endoplasmic reticulummembrane. J. Biol.
Chem. 278, 34774–34782.
Gardner, R.G., Swarbrick, G.M., Bays, N.W., Cronin, S.R., Wilhovsky, S., See-
lig, L., Kim, C., and Hampton, R.Y. (2000). Endoplasmic reticulum degradation
requires lumen to cytosol signaling. Transmembrane control of Hrd1p by
Hrd3p. J. Cell Biol. 151, 69–82.
Garza, R.M., Sato, B.K., and Hampton, R.Y. (2009). In vitro analysis of
Hrd1p-mediated retrotranslocation of its multispanning membrane substrate
3-hydroxy-3-methylglutaryl (HMG)-CoA reductase. J. Biol. Chem. 284,
14710–14722.
Gauss, R., Jarosch, E., Sommer, T., and Hirsch, C. (2006). A complex of Yos9p
and the HRD ligase integrates endoplasmic reticulum quality control into the
degradation machinery. Nat. Cell Biol. 8, 849–854.
Guerriero, C.J., and Brodsky, J.L. (2012). The delicate balance between
secreted protein folding and endoplasmic reticulum-associated degradation
in human physiology. Physiol. Rev. 92, 537–576.
Ha¨nzelmann, P., Buchberger, A., and Schindelin, H. (2011). Hierarchical bind-
ing of cofactors to the AAA ATPase p97. Structure 19, 833–843.
Hassink, G.C., Barel, M.T., Van Voorden, S.B., Kikkert, M., and Wiertz, E.J.
(2006). Ubiquitination of MHC class I heavy chains is essential for dislocation
by human cytomegalovirus-encoded US2 but not US11. J. Biol. Chem. 281,
30063–30071.ell 158, 1375–1388, September 11, 2014 ª2014 Elsevier Inc. 1387
Huyer, G., Piluek, W.F., Fansler, Z., Kreft, S.G., Hochstrasser, M., Brodsky,
J.L., and Michaelis, S. (2004). Distinct machinery is required in Saccharo-
myces cerevisiae for the endoplasmic reticulum-associated degradation of a
multispanning membrane protein and a soluble luminal protein. J. Biol.
Chem. 279, 38369–38378.
Jarosch, E., Taxis, C., Volkwein, C., Bordallo, J., Finley, D., Wolf, D.H., and
Sommer, T. (2002). Protein dislocation from the ER requires polyubiquitination
and the AAA-ATPase Cdc48. Nat. Cell Biol. 4, 134–139.
Liu, Y., and Ye, Y. (2012). Roles of p97-associated deubiquitinases in protein
quality control at the endoplasmic reticulum. Curr. Protein Pept. Sci. 13,
436–446.
Mehnert, M., Sommer, T., and Jarosch, E. (2014). Der1 promotes movement of
misfolded proteins through the endoplasmic reticulum membrane. Nat. Cell
Biol. 16, 77–86.
Meyer, H.H., Wang, Y., and Warren, G. (2002). Direct binding of ubiquitin con-
jugates by the mammalian p97 adaptor complexes, p47 and Ufd1-Npl4.
EMBO J. 21, 5645–5652.
Neuber, O., Jarosch, E., Volkwein, C., Walter, J., and Sommer, T. (2005). Ubx2
links the Cdc48 complex to ER-associated protein degradation. Nat. Cell Biol.
7, 993–998.
Park, E., and Rapoport, T.A. (2012). Mechanisms of Sec61/SecY-mediated
protein translocation across membranes. Annu. Rev. Biophys. 41, 21–40.
Plemper, R.K., Bordallo, J., Deak, P.M., Taxis, C., Hitt, R., and Wolf, D.H.
(1999). Genetic interactions of Hrd3p and Der3p/Hrd1p with Sec61p suggest
a retro-translocation complex mediating protein transport for ER degradation.
J. Cell Sci. 112, 4123–4134.
Rabinovich, E., Kerem, A., Fro¨hlich, K.U., Diamant, N., and Bar-Nun, S. (2002).
AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic
reticulum-associated protein degradation. Mol. Cell. Biol. 22, 626–634.
Ravid, T., Kreft, S.G., and Hochstrasser, M. (2006). Membrane and soluble
substrates of the Doa10 ubiquitin ligase are degraded by distinct pathways.
EMBO J. 25, 533–543.1388 Cell 158, 1375–1388, September 11, 2014 ª2014 Elsevier Inc.Rumpf, S., and Jentsch, S. (2006). Functional division of substrate processing
cofactors of the ubiquitin-selective Cdc48 chaperone. Mol. Cell 21, 261–269.
Sato, B.K., Schulz, D., Do, P.H., and Hampton, R.Y. (2009). Misfolded mem-
brane proteins are specifically recognized by the transmembrane domain of
the Hrd1p ubiquitin ligase. Mol. Cell 34, 212–222.
Schuberth, C., and Buchberger, A. (2005). Membrane-bound Ubx2 recruits
Cdc48 to ubiquitin ligases and their substrates to ensure efficient ER-associ-
ated protein degradation. Nat. Cell Biol. 7, 999–1006.
Shcherbik, N., and Haines, D.S. (2007). Cdc48p(Npl4p/Ufd1p) binds and
segregates membrane-anchored/tethered complexes via a polyubiquitin
signal present on the anchors. Mol. Cell 25, 385–397.
Swanson, R., Locher, M., and Hochstrasser, M. (2001). A conserved ubiquitin
ligase of the nuclear envelope/endoplasmic reticulum that functions in both
ER-associated and Matalpha2 repressor degradation. Genes Dev. 15, 2660–
2674.
Vashist, S., and Ng, D.T. (2004). Misfolded proteins are sorted by a sequential
checkpoint mechanism of ER quality control. J. Cell Biol. 165, 41–52.
Wang, X., Yu, Y.Y., Myers, N., and Hansen, T.H. (2013). Decoupling the role of
ubiquitination for the dislocation versus degradation of major histocompatibil-
ity complex (MHC) class I proteins during endoplasmic reticulum-associated
degradation (ERAD). J. Biol. Chem. 288, 23295–23306.
Xie, W., and Ng, D.T. (2010). ERAD substrate recognition in budding yeast.
Semin. Cell Dev. Biol. 21, 533–539.
Ye, Y., Meyer, H.H., and Rapoport, T.A. (2001). The AAA ATPase Cdc48/p97
and its partners transport proteins from the ER into the cytosol. Nature 414,
652–656.
Yu, H., and Kopito, R.R. (1999). The role of multiubiquitination in dislocation
and degradation of the alpha subunit of the T cell antigen receptor. J. Biol.
Chem. 274, 36852–36858.
